MedTrace Logo

Evaluation of Effects of CBD Products on Anxiety Among U.S. Women

NCT05108220 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1350

Last updated 2021-11-04

No results posted yet for this study

Summary

The investigators will conduct a retrospective cohort analysis of a consumer trial conducted by Rae Wellness. The trial took place between October 15, 2020 and December 30, 2020 and involved 1350 U.S. women who used in-home use tests (IHUT) of various Cannabidiol (CBD) products. Participants were randomized to one of 9 groups: 8 groups received one of 8 different CBD products in the mail, and one group served as the control and did not consume any CBD product. The CBD products varied by method of delivery, concentration of Tetrahydrocannabinol (THC), and dosage of CBD. Participants were asked to use the product once daily for 60 day and to complete health questionnaires at baseline, 30 days and 60 days.

Conditions

  • Anxiety
  • Generalized Anxiety Disorder

Interventions

DIETARY_SUPPLEMENT

Cannabidiol (CBD)- containing consumer products

Oils or capsules containing CBD which could be purchased commercially within the U.S.

Sponsors & Collaborators

  • Radicle Science

    lead INDUSTRY

Eligibility

Min Age
24 Years
Max Age
44 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-10-15
Primary Completion
2020-12-30
Completion
2020-12-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05108220 on ClinicalTrials.gov